More Business Wire
View Older Stories View Newer Stories-
Terremoto Biosciences Appoints James Christensen, Ph.D., as President and Head of Research & Development
-
Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer
-
Revvity Announces FDA Clearance for First Automated Free Testosterone Test
-
Tanger Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
-
Arrivo BioVentures Announces Positive Results from qEEG and BNA™ Study of SP-624 on Neural Brain Activity Related to Depression and Cognition
-
Addgene Expands Viral Vector Service with Packaged on Request
-
Savers Value Village, Inc. Announces Preliminary Fourth Quarter and Full Year Net Sales and Participation in the 27th Annual ICR Conference
-
SIXT USA Announces New Car Rental Branch at Louis Armstrong New Orleans International Airport
-
Leonardo DRS Schedules Fourth Quarter 2024 and Full Year 2024 Earnings Conference Call for February 20, 2025
-
Kardigan Launches with Industry-Leading Team to Modernize Cardiovascular Drug Development with Late-Stage Portfolio of Personalized Medicines
-
Character Biosciences Announces Collaboration with Bausch + Lomb to Transform Ophthalmology with Precision Medicine
-
Imperial Senior Vice President, Sustainability, Commercial Development and Product Solutions to assume new role at Exxon Mobil Corporation
-
E2open Announces Fiscal 2025 Third Quarter Financial Results
-
IonQ CEO on Timeline to Quantum Value
-
Zai Lab and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan region and Singapore
-
Vertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore
-
Lazard Hires Stephen Finkel as Managing Director and Global Head of Sports Advisory
-
Gannett to Present at the 27th Annual Needham Growth Conference
-
Cooler Master Launches the CH351: 3D Surround Sound Wireless Gaming Headset for Total Immersion
-
NeoGenomics Announces Chief Executive Officer Succession
-
U-Haul Opens New and Improved Full-Service Center in Schofield
-
Compass Pathways Announces Pricing of Underwritten Offering
-
Walgreens Boots Alliance Reports Fiscal 2025 First Quarter Results
-
CI Financial Announces Filing and Mailing of Circular for Special Meeting to Approve Plan of Arrangement with Mubadala Capital
-
Chemtrade Logistics Income Fund Issues 2025 Guidance and Raises Monthly Distribution
-
Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers
-
First of Four Next Health Nashville Locations Opening in The Gulch January 2025
-
AtlasClear Holdings, Inc. 2025 Stockholder Letter
-
Chemtrade Logistics Income Fund Announces Appointment of Trustee
-
Xeris Expects to Exceed Full-Year 2024 Financial Guidance
-
D-Wave Announces Fiscal Year 2024 Bookings Will Exceed $23 Million, Up Approximately 120% Over Fiscal Year 2023
-
RMHC Bay Area Welcomes Six New Board Members to Strengthen Mission and Community Engagement
-
Bunge Schedules Fourth Quarter 2024 Earnings Release and Conference Call
-
Constellation To Acquire Calpine; Creates America’s Leading Producer of Clean and Reliable Energy to Meet Growing Demand for Customers and Communities
-
KKR & Co. Inc. to Announce Fourth Quarter 2024 Results
-
Pfizer’s Sasanlimab in Combination with BCG Improves Event-Free Survival in Patients with BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer
-
Ronald S. Lauder to Retire from The Estée Lauder Companies’ Board of Directors
-
Astronics Corporation Announces Preliminary Unaudited Revenue for Fourth Quarter 2024 and Initiates Revenue Guidance for 2025
-
Lindsay Corporation Announces Quarterly Cash Dividend
-
Avery Dennison to Webcast Fourth Quarter and Full Year 2024 Earnings Conference Call
-
Marqeta to Announce Fourth Quarter and Full Year 2024 Results on February 26, 2025
-
Global Blue Releases the Monthly Tax Free Shopping Business Update for December 2024
-
Tikehau Capital: Disclosure of Shares Repurchases From 03 January 2025 to 09 January 2025
-
Insulet to Announce Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025
-
City Therapeutics Announces Strategic Collaboration with Bausch + Lomb to Develop a Novel RNAi-Based Treatment for Geographic Atrophy
-
Modivcare Raises $105 Million in Incremental Financing Backed by Stakeholders Across the Capital Structure and Takes Strategic Steps to Position Business for the Future
-
Li-Cycle Provides Preliminary Commercial and Operational Highlights for 2024
-
Becrypt Launches VDI Guard: Securing Critical Infrastructure by Mitigating Remote Access Protocol Vulnerabilities.
-
GlobalLogic Announces Leadership Change: Srini Shankar Appointed as President and Chief Executive Officer
-
Veteran-Owned Mischler Financial Group Welcomes Former J.P. Morgan Executive as Managing Director, Capital Markets
